Table 3.
Comparison of demographic characteristics and several important laboratory parameters between before and after treatment in patients with AP.
| BT | AT | P | |
|---|---|---|---|
| Male/female | 55/24 | ||
| Age | 50.85 ± 1.788 | ||
| AP (n = 79) | |||
| CRP (mg/mL) | 119.0 ± 13.26 | 56.29 ± 7.575 | P < 0.0001 |
| Amylase (U/L) | 444.7 ± 48.00 | 108.4 ± 10.68 | P < 0.0001 |
| Lipase (U/L) | 757.1 ± 90.50 | 155.9 ± 16.77 | P < 0.0001 |
| Hospitalization time (d) | 17.39 ± 1.302 | ||
| Severity of AP | |||
| M-AP (n = 68) | |||
| CRP (mg/mL) | 104.4 ± 12.34 | 42.25 ± 5.865 | P < 0.0001 |
| Amylase (U/L) | 434.0 ± 52.94 | 112.1 ± 12.10 | P < 0.0001 |
| Lipase (U/L) | 733.1 ± 97.62 | 154.5 ± 18.03 | P < 0.0001 |
| Hospitalization time (d) | 16.74 ± 1.420 | ||
| S-AP (n = 11) | |||
| CRP (mg/mL) | 231.7 ± 46.82 | 138.9 ± 31.72 | P = 0.0682 |
| Amylase (U/L) | 592.1 ± 110.5 | 91.55 ± 17.51 | P = 0.0137 |
| Lipase (U/L) | 1038 ± 243.2 | 142.8 ± 33.67 | P = 0.0098 |
| Hospitalization time (d) | 22.82 ± 2.885 | ||
P: BT vs. AT; BT: before treatment; AT: after treatment. Values are presented as mean ± SEM.